87 related articles for article (PubMed ID: 27620210)
1. Effect of Scavenging Circulating Reactive Carbonyls by Oral Pyridoxamine in Uremic Rats on Peritoneal Dialysis.
Mori Y; Kakuta T; Miyakogawa T; Takekoshi S; Yuzawa H; Kobayashi H; Kawakami A; Miyata T; Fukagawa M
Ther Apher Dial; 2016 Dec; 20(6):645-654. PubMed ID: 27620210
[TBL] [Abstract][Full Text] [Related]
2. Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats.
Kakuta T; Tanaka R; Satoh Y; Izuhara Y; Inagi R; Nangaku M; Saito A; Miyata T
Kidney Int; 2005 Sep; 68(3):1326-36. PubMed ID: 16105068
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
[TBL] [Abstract][Full Text] [Related]
4. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
[TBL] [Abstract][Full Text] [Related]
5. Removal of Protein-Bound Uremic Toxins by Liposome-Supported Peritoneal Dialysis.
Shi Y; Tian H; Wang Y; Shen Y; Zhu Q; Ding F
Perit Dial Int; 2019; 39(6):509-518. PubMed ID: 31690700
[No Abstract] [Full Text] [Related]
6. Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid.
Ishikawa N; Miyata T; Ueda Y; Inagi R; Izuhara Y; Yuzawa H; Onogi H; Nishina M; Nangaku M; Van Ypersele De Strihou C; Kurokawa K
Kidney Int; 2003 Jan; 63(1):331-9. PubMed ID: 12472800
[TBL] [Abstract][Full Text] [Related]
7. Efficient in vitro lowering of carbonyl stress by the glyoxalase system in conventional glucose peritoneal dialysis fluid.
Inagi R; Miyata T; Ueda Y; Yoshino A; Nangaku M; van Ypersele de Strihou C; Kurokawa K
Kidney Int; 2002 Aug; 62(2):679-87. PubMed ID: 12110033
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of glyoxal and methylglyoxal levels in uremic patients under peritoneal dialysis.
Lapolla A; Flamini R; Lupo A; Aricò NC; Rugiu C; Reitano R; Tubaro M; Ragazzi E; Seraglia R; Traldi P
Ann N Y Acad Sci; 2005 Jun; 1043():217-24. PubMed ID: 16037242
[TBL] [Abstract][Full Text] [Related]
9. New Insights into the Effects of Chronic Kidney Failure and Dialysate Exposure on the Peritoneum.
Vlahu CA; Aten J; de Graaff M; van Veen H; Everts V; de Waart DR; Struijk DG; Krediet RT
Perit Dial Int; 2016 11-12; 36(6):614-622. PubMed ID: 27147290
[TBL] [Abstract][Full Text] [Related]
10. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
11. Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion.
Pletinck A; Van Landschoot M; Steppan S; Laukens D; Passlick-Deetjen J; Vanholder R; Van Biesen W
Nephrol Dial Transplant; 2012 Feb; 27(2):548-56. PubMed ID: 21750165
[TBL] [Abstract][Full Text] [Related]
12. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
[TBL] [Abstract][Full Text] [Related]
13. Effects of new peritoneal dialysis solutions, pyridoxamine and AT1 receptor blocker, on TGF-beta1 and VEGF expression in rat peritoneal mesothelial cells.
Mizuiri S; Ohashi Y; Hemmi H; Arita M; Yamada K; Aoki T; Miyagi M; Sakai K; Aikawa A
Am J Nephrol; 2009; 30(3):295-302. PubMed ID: 19546527
[TBL] [Abstract][Full Text] [Related]
14. Nephrectomy and peritoneal dialysis eliminates circulating renin and controls uraemia in the rat.
Pedersen TF; Nielsen AH; Strandgaard S; Paulson OB
J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):130-4. PubMed ID: 12228855
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of peritoneal dialysis solutions on appetite in non-uremic rats.
Zheng ZH; Sederholm F; Anderstam B; Qureshi AR; Wang T; Södersten P; Bergström J; Lindholm B
Kidney Int; 2001 Dec; 60(6):2392-8. PubMed ID: 11737615
[TBL] [Abstract][Full Text] [Related]
16. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
Lui SL; Yung S; Yim A; Wong KM; Tong KL; Wong KS; Li CS; Au TC; Lo WK; Ho YW; Ng F; Tang C; Chan TM
Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
[TBL] [Abstract][Full Text] [Related]
18. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
[TBL] [Abstract][Full Text] [Related]
19. Effects of bicarbonate dialysis solution on peritoneal transport in rats.
Suzuki K; Khanna R; Nolph KD; Moore HL; Twardowski ZJ
Adv Perit Dial; 1996; 12():24-6. PubMed ID: 8865866
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 and vascular endothelial growth factor expressions are involved in ultrafiltration failure.
Guo J; Xiao J; Gao H; Jin Y; Zhao Z; Jiao W; Liu Z; Zhao Z
J Surg Res; 2014 May; 188(2):527-536.e2. PubMed ID: 24559584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
